Biologic therapy shown to reduce steroid use in 92% of severe asthmatics
A new study has found that using biologic therapy to reduce lung inflammation enabled 92% of people with severe asthma to reduce their dose of daily inhaled steroid without exacerbating their symptoms. The findings may mean that severe asthmatics can minimize the risk of adverse effects associated with long-term steroid use.Of the almost 300 million people in the world with asthma, around 3% to 5% have severe asthma, suffering from daily breathlessness, chest tightness and cough that frequently leads to hospitalization.…